Interventional Cardiology & Peripheral Vascular Devices Market Size by product (Interventional Catheters, Guidewires, Stents {Bioabsorbable Stents, Drug Eluting Stents, Bare Metal Stents}, PTCA Balloons, Atherectomy Devices, Chronic Total Occlusion Devices, Synthetic Surgical Grafts, Embolic Protection Devices, Inferior Vena Cava Filters), By Application (Congenital Heart Defect Correction, Coronary Thrombectomy, Angioplasty, Valvuloplasty, Percutaneous Valve Repair), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026

Published Date: Oct 2020  |  Report ID: GMI1964  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 227   |   Base Year: 2019




Summary Table of Contents Industry Coverage Methodology

Industry trends

Interventional Cardiology & Peripheral Vascular Devices Market size valued at USD 19.5 billion in 2019 and is projected to grow at a CAGR of over 7.6% from 2020 to 2026.
 

Interventional cardiology & peripheral vascular devices are being used to treat numerous cardiovascular conditions with the help of catheters, with minimal invasion. Minimally invasive cardiac procedures are gaining huge popularity as they cause less invasion, blood loss and pain. These procedures reduce hospital stay duration and visible scars, that help in driving the customer preference.
 

Interventional Cardiology & Peripheral Vascular Devices Market

Get more details on this report - Request Free Sample PDF
 

Advantages and innovations pertaining to interventional procedures along with increasing burden of coronary and peripheral arterial disorders (PAD) will spur the market growth. Every year, millions of people are diagnosed with PAD and coronary artery diseases. Additionally, adoption of smoking and consumption of sugar-rich food is increasing the risk of acquiring such diseases.  These diseases can result into stroke or heart attack and thus, must be treated on time.
 

Interventional Cardiology & Peripheral Vascular Devices Market Report Coverage
Report Coverage Details
Base Year: 2019 Market Size in 2019: USD 19.9 Billion
Historical Data for: 2015 to 2019 Forecast Period: 2020 to 2026
Forecast Period 2020 to 2026 CAGR: 7.6% 2026 Value Projection: USD 33.0 Billion
Pages: 227 Tables, Charts & Figures: 190
Geographies covered (15): U.S., Canada, UK, France, Germany, Spain, Italy, China, India, Japan, Brazil, Mexico, Argentina, South Africa, Saudi Arabia
Segments covered: Product, Application, End-use
Companies covered (11): Abbott Laboratories, AngioDynamics, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical, W. L. Gore & Associates Inc., Teleflex, Inc., Medtronic plc, Cardinal Health, C.R. Bard (Becton Dickinson and Company), B. Braun Melsungen AG
Growth Drivers:
  • Growing prevalence of vascular diseases worldwide
  • Technological advancements in peripheral vascular devices
  • Rising adoption of minimally invasive procedures
  • Increasing government spending pertaining to cardiovascular diseases burden
Pitfalls & Challenges:
  • Stringent regulatory framework
  • Post-procedural complications associated with devices

Get more details on this report - Request Free Sample PDF
 

Increasing focus on installing and expanding catheterization laboratory facilities will benefit peripheral interventions industry

Growing number of cardiac catheterization laboratories (cath lab) will positively impact interventional cardiology market demand through 2026. Number of cath labs in developed and emerging economies is witnessing rapid growth. Several hospitals are renewing their cath lab departments; few physicians are also setting-up standalone catheterization laboratories. Moreover, improving infrastructure, especially in developing countries ease the accessibility to patients, thereby further augmenting procedure adoption.
 

However, stringent regulations for set-up of cath labs as well as peripheral vascular devices can restrain the market expansion up to some extent. Risk associated with post-procedural effects of some interventional procedures will limit the market value.
 

Advancements in stents will create attractive market growth opportunities

Stents segment held more than 40% of the interventional cardiology & peripheral vascular devices market share in 2019 owing to innovations in stents such as introduction of bioresorbable stents and stents developed with advanced materials to avoid restenosis. Moreover, growing number of angioplasties in countries such as China and India due to large geriatric pool, high prevalence of cardiac disorders and price capping are poised to push the segment growth. However, over-stenting in countries including the U.S. may limit the market expansion.
 

Growing incidence of arterial diseases will increase adoption of angioplasties in Asia Pacific region

Angioplasty application accounted for significant market revenue in 2019 led by rising number of angioplasties in Asian countries. Increasing prevalence of arteriosclerosis, hypertension and other arterial disorders will further augment the demand.
 

Percutaneous valve repair segment is estimated to observe around 9.5% growth rate till 2026. Rising prevalence of valve disorders will highly influence the adoption of percutaneous valve repair procedures. Preference for minimally invasive surgeries assists in driving the demand for such procedures. Additionally, the procedure is suitable in patients that cannot undergo surgery.
 

High potential and investment of hospitals on catheterization department

Hospitals end-use segment in the interventional cardiology & peripheral vascular devices market exceeded USD 17 billion revenue in 2019 impelled by developed infrastructure and capacity to spend on advanced and specialized catheterization lab equipment.
 

Numerous hospitals in emerging countries including India are opening cath labs and hybrid cath labs. These new facilities are being equipped with advanced devices and facilities that are proving beneficial for rising number of cardiac patients. Furthermore, hospitals in developed nations are also spending to improve the infrastructure and addition of innovative solutions to their interventional cardio technology.
 

Rising number of product approvals and increasing cardiovascular procedure trend will highly influence APAC market growth

APAC Interventional Cardiology & Peripheral Vascular Devices Market

Get more details on this report - Request Free Sample PDF
 

Asia Pacific interventional cardiology & peripheral vascular devices market covered above 40% revenue share in 2019. Japan dominated the APAC market in 2019 on account of increasing number of product approvals. For instance, in September 2019,  OrbusNeich announced approval for its COMBO Plus Coronary Stent in Japan. The device approval with novel one of its kind technology will enhance company’s product reach as well as benefit market size.  
 

Large geriatric pool, suffering from various chronic diseases will assist the market expansion. With high prevalence of cardiovascular disorders and vulnerability to suffer from comorbidities, adoption of cardiovascular procedures including angioplasty will rapidly increase. Furthermore, growing disposable income and accessibility to specialized cardiac centers will further fuel the regional market value.
 

Prominent industry players are focusing on strategic alliances

Some of the prominent players operating in the interventional cardiology & peripheral vascular devices market include Boston Scientific Corporation, Medtronic plc, Johnson & Johnson, Abbott Laboratories and B. Braun Melsungen AG. These market leaders are adopting several strategies such as product innovations and inorganic growth strategies to achieve competitive edge over other companies.
 

Some of the recent industry developments:

  • In October 2020, the company announced long-term collaboration with the Association for Vascular Access aimed to improve Peripheral Intravenous Catheters training. This will help the company to broaden its customer base and geographical presence.
     
  • In August 2019, Boston Scientific acquired BTG plc., a company involved in development and commercialization of products used in minimally invasive procedures used in treatment of vascular and cancer disorders. This alliance aid in expanding the firm’s interventional and vascular product portfolio. It also helped to strengthen the technology and infrastructure of the company.
     
  • In January 2018, Medtronic purchased the Chocolate PTA non-drug-coated balloon, designed and developed by QT Vascular. QT Vascular Inc. global company engaged in the design and distribution of advanced therapeutic solutions for treatment of vascular disease. This strategy helped the company to provide comprehensive product portfolio.
     

This market research report interventional cardiology & peripheral vascular devices includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2015 to 2026, for the following segments:
 

Market, By Product

  • Interventional Catheters
  • Guidewires
  • Stents
    • Bioabsorbable Stents
    • Drug Eluting stents
    • Bare Metal Stents
    • Others
  • PTCA Balloons
  • Atherectomy Devices
  • Chronic Total Occlusion Devices
  • Synthetic Surgical Grafts
  • Embolic Protection Devices
  • IVC filters
  • Others

Market, By Application

  • Congenital Heart Defect Correction
  • Coronary Thrombectomy
  • Angioplasty
  • Valvuloplasty
  • Percutaneous Valve Repair
  • Others

Market, By End-use

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
       

Frequently Asked Questions (FAQ) :

In 2019, the global Market size was worth USD 19.5 billion. It is estimated to register over 7.6% CAGR from 2020 to 2026.
Stents segment accounted for 40% industry share in 2019 and may depict considerable traction on account of stent innovations such as launch of bioresorbable stents.
The global market may exhibit 9.5% growth rate through 2026, from percutaneous valve repair application segment, owing to increasing prevalence of valve disorders.
Hospitals end-use segment held USD 17 billion revenue in 2019 and may majorly impel the industry size, driven by the advanced infrastructure and capacity to pour in capital for specialized catheterization lab equipment.
APAC market captured 40% revenue share in 2019, with Japan emerging as the dominant region, owing to rising number of product approvals.

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Oct 2020
  • Pages: 227
  • Tables: 175
  • Charts / Figures: 15
  • Companies covered: 11
  • Countries covered: 15

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X